{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:57:42Z","timestamp":1794430662866,"version":"4.9.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["214915"],"award-info":[{"award-number":["214915"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["218053"],"award-info":[{"award-number":["218053"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["302686\/2014-2"],"award-info":[{"award-number":["302686\/2014-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["AZ140097"],"award-info":[{"award-number":["AZ140097"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["NIH\/NIMHD L32 MD009205-01"],"award-info":[{"award-number":["NIH\/NIMHD L32 MD009205-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["NIH\/NINDS 1R01 NS091329-01"],"award-info":[{"award-number":["NIH\/NINDS 1R01 NS091329-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is associated with memory impairment and altered peripheral metabolism. Mounting evidence indicates that abnormal signaling in a brain-periphery metabolic axis plays a role in AD pathophysiology. The activation of pro-inflammatory pathways in the brain, including the interleukin-6 (IL-6) pathway, comprises a potential point of convergence between memory dysfunction and metabolic alterations in AD that remains to be better explored. Using T2-weighted magnetic resonance imaging (MRI), we observed signs of probable inflammation in the hypothalamus and in the hippocampus of AD patients when compared to cognitively healthy control subjects. Pathological examination of <jats:italic>post-mortem<\/jats:italic> AD hypothalamus revealed the presence of hyperphosphorylated tau and tangle-like structures, as well as parenchymal and vascular amyloid deposits surrounded by astrocytes. T2 hyperintensities on MRI positively correlated with plasma IL-6, and both correlated inversely with cognitive performance and hypothalamic\/hippocampal volumes in AD patients. Increased IL-6 and suppressor of cytokine signaling 3 (SOCS3) were observed in <jats:italic>post-mortem<\/jats:italic> AD brains. Moreover, activation of the IL-6 pathway was observed in the hypothalamus and hippocampus of AD mice. Neutralization of IL-6 and inhibition of the signal transducer and activator of transcription 3 (STAT3) signaling in the brains of AD mouse models alleviated memory impairment and peripheral glucose intolerance, and normalized plasma IL-6 levels. Collectively, these results point to IL-6 as a link between cognitive impairment and peripheral metabolic alterations in AD. Targeting pro-inflammatory IL-6 signaling may be a strategy to alleviate memory impairment and metabolic alterations in the disease.<\/jats:p>","DOI":"10.1038\/s41398-021-01349-z","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T05:02:51Z","timestamp":1619586171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":328,"title":["Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Natalia M.","family":"Lyra e Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaella A.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9057-8014","authenticated-orcid":false,"given":"Tharick A.","family":"Pascoal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo A. S.","family":"Lima-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa de Paula Fran\u00e7a","family":"Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L. M.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9621-5422","authenticated-orcid":false,"given":"Antonio L.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo C.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julyanna A.","family":"Peny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana T. S.","family":"Fortuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isadora C.","family":"Furigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian S.","family":"Miya-Coreixas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia R.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose F.","family":"Abisambra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2638-8061","authenticated-orcid":false,"given":"Beatriz M.","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4166-7608","authenticated-orcid":false,"suffix":"Jr.","given":"Jose","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9116-1376","authenticated-orcid":false,"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Caramelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7160-9866","authenticated-orcid":false,"given":"Sergio T.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8358-0589","authenticated-orcid":false,"given":"Fernanda G.","family":"De Felice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"1349_CR1","first-page":"459","volume":"12","author":"A Alzheimer\u2019s","year":"2016","unstructured":"Alzheimer\u2019s, A. Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. J. Alzheimer\u2019s Assoc. 12, 459\u2013509 (2016).","journal-title":"J. Alzheimer\u2019s Assoc."},{"key":"1349_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.15252\/emmm.201404183","volume":"7","author":"JR Clarke","year":"2015","unstructured":"Clarke, J. R. et al. Alzheimer-associated Abeta oligomers impact the central nervous system to induce peripheral metabolic deregulation. EMBO Mol. Med. 7, 190\u2013210 (2015).","journal-title":"EMBO Mol. Med."},{"key":"1349_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1212\/WNL.50.1.164","volume":"50","author":"S Craft","year":"1998","unstructured":"Craft, S. et al. Cerebrospinal fluid and plasma insulin levels in Alzheimer\u2019s disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 50, 164\u2013168 (1998).","journal-title":"Neurology"},{"key":"1349_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3233\/JAD-2010-100795","volume":"22","author":"FJ Gil-Bea","year":"2010","unstructured":"Gil-Bea, F. J. et al. Insulin levels are decreased in the cerebrospinal fluid of women with prodomal Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis.: JAD 22, 405\u2013413 (2010).","journal-title":"J. Alzheimer\u2019s Dis.: JAD"},{"key":"1349_CR5","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","volume":"53","author":"J Janson","year":"2004","unstructured":"Janson, J. et al. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53, 474\u2013481 (2004).","journal-title":"Diabetes"},{"key":"1349_CR6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00592-013-0546-y","volume":"51","author":"M Heni","year":"2014","unstructured":"Heni, M. et al. Evidence for altered transport of insulin across the blood-brain barrier in insulin-resistant humans. Acta diabetologica 51, 679\u2013681 (2014).","journal-title":"Acta diabetologica"},{"key":"1349_CR7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3389\/fnagi.2017.00399","volume":"9","author":"R Takechi","year":"2017","unstructured":"Takechi, R. et al. Blood-brain barrier dysfunction precedes cognitive decline and neurodegeneration in diabetic insulin resistant mouse model: an implication for causal link. Front. Aging Neurosci. 9, 399 (2017).","journal-title":"Front. Aging Neurosci."},{"key":"1349_CR8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2174\/1570159X15666170720095240","volume":"16","author":"M Fakhoury","year":"2018","unstructured":"Fakhoury, M. Microglia and astrocytes in Alzheimer\u2019s disease: implications for therapy. Curr. Neuropharmacol. 16, 508\u2013518 (2018).","journal-title":"Curr. Neuropharmacol."},{"key":"1349_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 14, 388\u2013405 (2015).","journal-title":"Lancet Neurol."},{"key":"1349_CR10","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1016\/j.jalz.2013.12.010","volume":"10","author":"ST Ferreira","year":"2014","unstructured":"Ferreira, S. T., Clarke, J. R., Bomfim, T. R. & De Felice, F. G. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer\u2019s disease. Alzheimer\u2019s Dement.: J. Alzheimer\u2019s Assoc. 10, S76\u2013S83 (2014).","journal-title":"Alzheimer\u2019s Dement.: J. Alzheimer\u2019s Assoc."},{"key":"1349_CR11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","volume":"18","author":"MV Lourenco","year":"2013","unstructured":"Lourenco, M. V. et al. TNF-alpha mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer\u2019s beta-amyloid oligomers in mice and monkeys. Cell Metab. 18, 831\u2013843 (2013).","journal-title":"Cell Metab."},{"key":"1349_CR12","first-page":"136","volume":"3","author":"WY Wang","year":"2015","unstructured":"Wang, W. Y., Tan, M. S., Yu, J. T. & Tan, L. Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann. Transl. Med. 3, 136 (2015).","journal-title":"Ann. Transl. Med."},{"key":"1349_CR13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/j.1749-6632.2000.tb05426.x","volume":"917","author":"AJ Dunn","year":"2000","unstructured":"Dunn, A. J. Cytokine activation of the HPA axis. Ann. N. Y. Acad. Sci. 917, 608\u2013617 (2000).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1349_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bbi.2016.10.020","volume":"62","author":"E Elwood","year":"2017","unstructured":"Elwood, E., Lim, Z., Naveed, H. & Galea, I. The effect of systemic inflammation on human brain barrier function. Brain, Behav., Immun. 62, 35\u201340 (2017).","journal-title":"Brain, Behav., Immun."},{"key":"1349_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/clpt.2014.147","volume":"96","author":"BM Bettcher","year":"2014","unstructured":"Bettcher, B. M. & Kramer, J. H. Longitudinal inflammation, cognitive decline, and Alzheimer\u2019s disease: a mini-review. Clin. Pharmacol. therapeutics 96, 464\u2013469 (2014).","journal-title":"Clin. Pharmacol. therapeutics"},{"key":"1349_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neuroscience.2019.09.008","volume":"421","author":"VG Fraga","year":"2019","unstructured":"Fraga, V. G. et al. Inflammatory and pro-resolving mediators in frontotemporal dementia and Alzheimer\u2019s disease. Neuroscience 421, 123\u2013135 (2019).","journal-title":"Neuroscience"},{"key":"1349_CR17","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/ene.12921","volume":"23","author":"K Miwa","year":"2016","unstructured":"Miwa, K., Okazaki, S., Sakaguchi, M., Mochizuki, H. & Kitagawa, K. Interleukin-6, interleukin-6 receptor gene variant, small-vessel disease and incident dementia. Eur. J. Neurol. 23, 656\u2013663 (2016).","journal-title":"Eur. J. Neurol."},{"key":"1349_CR18","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1111\/jgs.13165","volume":"62","author":"BG Windham","year":"2014","unstructured":"Windham, B. G. et al. Associations between inflammation and cognitive function in African Americans and European Americans. J. Am. Geriatrics Soc. 62, 2303\u20132310 (2014).","journal-title":"J. Am. Geriatrics Soc."},{"key":"1349_CR19","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/BF00571510","volume":"89","author":"M Huell","year":"1995","unstructured":"Huell, M., Strauss, S., Volk, B., Berger, M. & Bauer, J. Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer\u2019s disease patients. Acta Neuropathol. 89, 544\u2013551 (1995).","journal-title":"Acta Neuropathol."},{"key":"1349_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yexcr.2004.01.002","volume":"295","author":"RA Quintanilla","year":"2004","unstructured":"Quintanilla, R. A., Orellana, D. I., Gonzalez-Billault, C. & Maccioni, R. B. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5\/p35 pathway. Exp. Cell Res. 295, 245\u2013257 (2004).","journal-title":"Exp. Cell Res."},{"key":"1349_CR21","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.bbi.2011.10.008","volume":"26","author":"MD Burton","year":"2012","unstructured":"Burton, M. D. & Johnson, R. W. Interleukin-6 trans-signaling in the senescent mouse brain is involved in infection-related deficits in contextual fear conditioning. Brain Behav. Immun. 26, 732\u2013738 (2012).","journal-title":"Brain Behav. Immun."},{"key":"1349_CR22","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1073\/pnas.94.4.1500","volume":"94","author":"CJ Heyser","year":"1997","unstructured":"Heyser, C. J., Masliah, E., Samimi, A., Campbell, I. L. & Gold, L. H. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc. Natl Acad. Sci. USA 94, 1500\u20131505 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1349_CR23","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","volume":"50","author":"F Brosseron","year":"2014","unstructured":"Brosseron, F., Krauthausen, M., Kummer, M. & Heneka, M. T. Body fluid cytokine levels in mild cognitive impairment and Alzheimer\u2019s disease: a comparative overview. Mol. Neurobiol. 50, 534\u2013544 (2014).","journal-title":"Mol. Neurobiol."},{"key":"1349_CR24","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","volume":"68","author":"W Swardfager","year":"2010","unstructured":"Swardfager, W. et al. A meta-analysis of cytokines in Alzheimer\u2019s disease. Biol. Psychiatry 68, 930\u2013941 (2010).","journal-title":"Biol. Psychiatry"},{"key":"1349_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7, 263\u2013269 (2011).","journal-title":"Alzheimers Dement"},{"key":"1349_CR26","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1590\/S0004-282X2003000500014","volume":"61","author":"SM Brucki","year":"2003","unstructured":"Brucki, S. M., Nitrini, R., Caramelli, P., Bertolucci, P. H. & Okamoto, I. H. Suggestions for utilization of the mini-mental state examination in Brazil. Arquivos de. neuro-psiquiatria 61, 777\u2013781 (2003).","journal-title":"Arquivos de. neuro-psiquiatria"},{"key":"1349_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1590\/S1980-57642009DN30100011","volume":"3","author":"TH Machado","year":"2009","unstructured":"Machado, T. H. et al. Normative data for healthy elderly on the phonemic verbal fluency task - FAS. Dement. Neuropsychol. 3, 55\u201360 (2009).","journal-title":"Dement. Neuropsychol."},{"key":"1349_CR28","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1017\/S1355617704104062","volume":"10","author":"R Nitrini","year":"2004","unstructured":"Nitrini, R. et al. Performance of illiterate and literate nondemented elderly subjects in two tests of long-term memory. J. Int. Neuropsychol. Soc. 10, 634\u2013638 (2004).","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"1349_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1590\/S1980-57642008DN10100010","volume":"1","author":"RG Beato","year":"2007","unstructured":"Beato, R. G., Nitrini, R., Formigoni, A. P. & Caramelli, P. Brazilian version of the Frontal Assessment Battery (FAB): preliminary data on administration to healthy elderly. Dement. Neuropsychologia 1, 59\u201365 (2007).","journal-title":"Dement. Neuropsychologia"},{"key":"1349_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.63","volume":"5","author":"WM Pauli","year":"2018","unstructured":"Pauli, W. M., Nili, A. N. & Tyszka, J. M. A high-resolution probabilistic in vivo atlas of human subcortical brain nuclei. Sci. data 5, 180063 (2018).","journal-title":"Sci. data"},{"key":"1349_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fnins.2012.00171","volume":"6","author":"A Klein","year":"2012","unstructured":"Klein, A. & Tourville, J. 101 labeled brain images and a consistent human cortical labeling protocol. Front. Neurosci. 6, 171 (2012).","journal-title":"Front. Neurosci."},{"key":"1349_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10217-w","volume":"10","author":"TA Pascoal","year":"2019","unstructured":"Pascoal, T. A. et al. Abeta-induced vulnerability propagates via the brain\u2019s default mode network. Nat. Commun. 10, 2353 (2019).","journal-title":"Nat. Commun."},{"key":"1349_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1535-7511.2005.00059.x","volume":"5","author":"GD Cascino","year":"2005","unstructured":"Cascino, G. D. Temporal lobe epilepsy: more than hippocampal pathology. Epilepsy Curr. 5, 187\u2013189 (2005).","journal-title":"Epilepsy Curr."},{"key":"1349_CR34","first-page":"373","volume":"6","author":"F Deulofeu Fontanillas","year":"1989","unstructured":"Deulofeu Fontanillas, F. et al. Massive hemoptysis secondary to mycotic aortic aneurysm. de. Med. interna 6, 373\u2013375 (1989).","journal-title":"de. Med. interna"},{"key":"1349_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.schres.2015.05.034","volume":"173","author":"O Pasternak","year":"2016","unstructured":"Pasternak, O., Kubicki, M. & Shenton, M. E. In vivo imaging of neuroinflammation in schizophrenia. Schizophrenia Res 173, 200\u2013212 (2016).","journal-title":"Schizophrenia Res"},{"key":"1349_CR36","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1212\/WNL.0000000000004363","volume":"89","author":"PVS Souza","year":"2017","unstructured":"Souza, P. V. S., Bortholin, T., Naylor, F. G. M., Pinto, W. & Oliveira, A. S. B. Teaching NeuroImages: early-onset dementia and demyelinating neuropathy disclosing cerebrotendinous xanthomatosis. Neurology 89, e134 (2017).","journal-title":"Neurology"},{"key":"1349_CR37","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1111\/ejn.13044","volume":"42","author":"A Virel","year":"2015","unstructured":"Virel, A. et al. Magnetic resonance imaging as a tool to image neuroinflammation in a rat model of Parkinson\u2019s disease\u2013phagocyte influx to the brain is promoted by bilberry-enriched diet. Eur. J. Neurosci. 42, 2761\u20132771 (2015).","journal-title":"Eur. J. Neurosci."},{"key":"1349_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1172\/JCI59660","volume":"122","author":"JP Thaler","year":"2012","unstructured":"Thaler, J. P. et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Investig. 122, 153\u2013162 (2012).","journal-title":"J. Clin. Investig."},{"key":"1349_CR39","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert, M. P. et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95, 6448\u20136453 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1349_CR40","doi-asserted-by":"publisher","first-page":"9626","DOI":"10.1523\/JNEUROSCI.0482-13.2013","volume":"33","author":"CP Figueiredo","year":"2013","unstructured":"Figueiredo, C. P. et al. Memantine rescues transient cognitive impairment caused by high-molecular-weight abeta oligomers but not the persistent impairment induced by low-molecular-weight oligomers. J. Neurosci.: . J. Soc. Neurosci. 33, 9626\u20139634 (2013).","journal-title":"J. Neurosci.: . J. Soc. Neurosci."},{"key":"1349_CR41","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1074\/jbc.M116.753525","volume":"292","author":"GS Seixas da Silva","year":"2017","unstructured":"Seixas da Silva, G. S. et al. Amyloid-beta oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons. J. Biol. Chem. 292, 7395\u20137406 (2017).","journal-title":"J. Biol. Chem."},{"key":"1349_CR42","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1073\/pnas.0809158106","volume":"106","author":"FG De Felice","year":"2009","unstructured":"De Felice, F. G. et al. Protection of synapses against Alzheimer\u2019s-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc. Natl Acad. Sci. USA 106, 1971\u20131976 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1349_CR43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/path.5056","volume":"245","author":"AF Batista","year":"2018","unstructured":"Batista, A. F. et al. The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer\u2019s disease. J. Pathol. 245, 85\u2013100 (2018).","journal-title":"J. Pathol."},{"key":"1349_CR44","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1210\/en.2010-0651","volume":"151","author":"J Donato Jr.","year":"2010","unstructured":"Donato, J. Jr., Frazao, R., Fukuda, M., Vianna, C. R. & Elias, C. F. Leptin induces phosphorylation of neuronal nitric oxide synthase in defined hypothalamic neurons. Endocrinology 151, 5415\u20135427 (2010).","journal-title":"Endocrinology"},{"key":"1349_CR45","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"1349_CR46","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1210\/en.2014-1121","volume":"155","author":"KE Berkseth","year":"2014","unstructured":"Berkseth, K. E. et al. Hypothalamic gliosis associated with high-fat diet feeding is reversible in mice: a combined immunohistochemical and magnetic resonance imaging study. Endocrinology 155, 2858\u20132867 (2014).","journal-title":"Endocrinology"},{"key":"1349_CR47","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/WNL.58.2.265","volume":"58","author":"RS Briellmann","year":"2002","unstructured":"Briellmann, R. S., Kalnins, R. M., Berkovic, S. F. & Jackson, G. D. Hippocampal pathology in refractory temporal lobe epilepsy: T2-weighted signal change reflects dentate gliosis. Neurology 58, 265\u2013271 (2002).","journal-title":"Neurology"},{"key":"1349_CR48","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1212\/WNL.57.9.1669","volume":"57","author":"DJ Callen","year":"2001","unstructured":"Callen, D. J., Black, S. E., Gao, F., Caldwell, C. B. & Szalai, J. P. Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology 57, 1669\u20131674 (2001).","journal-title":"Neurology"},{"key":"1349_CR49","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.cmet.2015.08.016","volume":"22","author":"M Ishii","year":"2015","unstructured":"Ishii, M. & Iadecola, C. Metabolic and non-cognitive manifestations of Alzheimer\u2019s disease: the hypothalamus as both culprit and target of pathology. Cell Metab. 22, 761\u2013776 (2015).","journal-title":"Cell Metab."},{"key":"1349_CR50","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3233\/JAD-2010-1364","volume":"20","author":"N Loskutova","year":"2010","unstructured":"Loskutova, N., Honea, R. A., Brooks, W. M. & Burns, J. M. Reduced limbic and hypothalamic volumes correlate with bone density in early Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 20, 313\u2013322 (2010).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"1349_CR51","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3233\/JAD-160887","volume":"55","author":"N Iwahara","year":"2017","unstructured":"Iwahara, N. et al. Role of suppressor of cytokine signaling 3 (SOCS3) in altering activated microglia phenotype in APPswe\/PS1dE9 mice. J. Alzheimer\u2019s Dis. 55, 1235\u20131247 (2017).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"1349_CR52","doi-asserted-by":"publisher","first-page":"116645","DOI":"10.1016\/j.jns.2019.116645","volume":"410","author":"L Gjerum","year":"2019","unstructured":"Gjerum, L. et al. A visual rating scale for cingulate island sign on 18F-FDG-PET to differentiate dementia with Lewy bodies and Alzheimer\u2019s disease. J. Neurological Sci. 410, 116645 (2019).","journal-title":"J. Neurological Sci."},{"key":"1349_CR53","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3233\/JAD-190773","volume":"73","author":"D Wong","year":"2020","unstructured":"Wong, D. et al. Reduced hippocampal glutamate and posterior cingulate N-acetyl aspartate in mild cognitive impairment and Alzheimer\u2019s disease is associated with episodic memory performance and white matter integrity in the cingulum: a pilot study. J. Alzheimer\u2019s Dis. 73, 1385\u20131405 (2020).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"1349_CR54","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.nlm.2011.08.003","volume":"96","author":"ST Ferreira","year":"2011","unstructured":"Ferreira, S. T. & Klein, W. L. The Abeta oligomer hypothesis for synapse failure and memory loss in Alzheimer\u2019s disease. Neurobiol. Learn. Mem. 96, 529\u2013543 (2011).","journal-title":"Neurobiol. Learn. Mem."},{"key":"1349_CR55","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297, 353\u2013356 (2002).","journal-title":"Science"},{"key":"1349_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.120","volume":"2","author":"SJ Sukoff Rizzo","year":"2012","unstructured":"Sukoff Rizzo, S. J. et al. Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Transl. Psychiatry 2, e199 (2012).","journal-title":"Transl. Psychiatry"},{"key":"1349_CR57","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/mp.2008.105","volume":"14","author":"T Chiba","year":"2009","unstructured":"Chiba, T. et al. Amyloid-beta causes memory impairment by disturbing the JAK2\/STAT3 axis in hippocampal neurons. Mol. Psychiatry 14, 206\u2013222 (2009).","journal-title":"Mol. Psychiatry"},{"key":"1349_CR58","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1007\/s001250050588","volume":"39","author":"A Ott","year":"1996","unstructured":"Ott, A. et al. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 39, 1392\u20131397 (1996).","journal-title":"Diabetologia"},{"key":"1349_CR59","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","volume":"53","author":"A Ott","year":"1999","unstructured":"Ott, A. et al. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 53, 1937\u20131942 (1999).","journal-title":"Neurology"},{"key":"1349_CR60","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1212\/01.wnl.0000306313.89165.ef","volume":"71","author":"RA Whitmer","year":"2008","unstructured":"Whitmer, R. A. et al. Central obesity and increased risk of dementia more than three decades later. Neurology 71, 1057\u20131064 (2008).","journal-title":"Neurology"},{"key":"1349_CR61","first-page":"1964","volume":"27","author":"A Spilt","year":"2006","unstructured":"Spilt, A. et al. Not all age-related white matter hyperintensities are the same: a magnetization transfer imaging study. AJNR Am. J. Neuroradiol. 27, 1964\u20131968 (2006).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"1349_CR62","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/hbm.23042","volume":"37","author":"EM Blessing","year":"2016","unstructured":"Blessing, E. M., Beissner, F., Schumann, A., Brunner, F. & Bar, K. J. A data-driven approach to mapping cortical and subcortical intrinsic functional connectivity along the longitudinal hippocampal axis. Hum. brain Mapp. 37, 462\u2013476 (2016).","journal-title":"Hum. brain Mapp."},{"key":"1349_CR63","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"1349_CR64","first-page":"243","volume":"134","author":"K Ogomori","year":"1989","unstructured":"Ogomori, K. et al. Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer\u2019s disease. Am. J. Pathol. 134, 243\u2013251 (1989).","journal-title":"Am. J. Pathol."},{"key":"1349_CR65","first-page":"681","volume":"139","author":"DG Standaert","year":"1991","unstructured":"Standaert, D. G., Lee, V. M., Greenberg, B. D., Lowery, D. E. & Trojanowski, J. Q. Molecular features of hypothalamic plaques in Alzheimer\u2019s disease. Am. J. Pathol. 139, 681\u2013691 (1991).","journal-title":"Am. J. Pathol."},{"key":"1349_CR66","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.neurobiolaging.2011.03.014","volume":"33","author":"R Fronczek","year":"2012","unstructured":"Fronczek, R. et al. Hypocretin (orexin) loss in Alzheimer\u2019s disease. Neurobiol. aging 33, 1642\u20131650 (2012).","journal-title":"Neurobiol. aging"},{"key":"1349_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2014.121","volume":"47","author":"ES Musiek","year":"2015","unstructured":"Musiek, E. S., Xiong, D. D. & Holtzman, D. M. Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease. Exp. Mol. Med. 47, e148 (2015).","journal-title":"Exp. Mol. Med."},{"key":"1349_CR68","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbi.2017.04.007","volume":"64","author":"GC Kincheski","year":"2017","unstructured":"Kincheski, G. C. et al. Chronic sleep restriction promotes brain inflammation and synapse loss, and potentiates memory impairment induced by amyloid-beta oligomers in mice. Brain, Behav., Immun. 64, 140\u2013151 (2017).","journal-title":"Brain, Behav., Immun."},{"key":"1349_CR69","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1096\/fj.04-1625fje","volume":"18","author":"D Balschun","year":"2004","unstructured":"Balschun, D. et al. Interleukin-6: a cytokine to forget. FASEB J.: . Publ. Federation Am. Societies Exp. Biol. 18, 1788\u20131790 (2004).","journal-title":"FASEB J.: . Publ. Federation Am. Societies Exp. Biol."},{"key":"1349_CR70","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1046\/j.1471-4159.2001.00121.x","volume":"76","author":"DK Song","year":"2001","unstructured":"Song, D. K. et al. Central beta-amyloid peptide-induced peripheral interleukin-6 responses in mice. J. Neurochem 76, 1326\u20131335 (2001).","journal-title":"J. Neurochem"},{"key":"1349_CR71","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/01688639208402827","volume":"14","author":"S Craft","year":"1992","unstructured":"Craft, S., Zallen, G. & Baker, L. D. Glucose and memory in mild senile dementia of the Alzheimer type. J. Clin. Exp. Neuropsychol. 14, 253\u2013267 (1992).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"1349_CR72","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jstrokecerebrovasdis.2005.08.009","volume":"15","author":"CB Wright","year":"2006","unstructured":"Wright, C. B. et al. Interleukin-6 is associated with cognitive function: the Northern Manhattan Study. J. Stroke Cerebrovasc. Dis.: . J. Natl Stroke Assoc. 15, 34\u201338 (2006).","journal-title":"J. Stroke Cerebrovasc. Dis.: . J. Natl Stroke Assoc."},{"key":"1349_CR73","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrendo.2012.189","volume":"8","author":"VA Pavlov","year":"2012","unstructured":"Pavlov, V. A. & Tracey, K. J. The vagus nerve and the inflammatory reflex\u2013linking immunity and metabolism. Nat. Rev. Endocrinol. 8, 743\u2013754 (2012).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1349_CR74","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fnins.2019.00303","volume":"13","author":"E Gyengesi","year":"2019","unstructured":"Gyengesi, E. et al. Chronic microglial activation in the GFAP-IL6 mouse contributes to age-dependent cerebellar volume loss and impairment in motor function. Front. Neurosci. 13, 303 (2019).","journal-title":"Front. Neurosci."},{"key":"1349_CR75","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/mp.2012.168","volume":"18","author":"JH Ledo","year":"2013","unstructured":"Ledo, J. H. et al. Amyloid-beta oligomers link depressive-like behavior and cognitive deficits in mice. Mol. psychiatry 18, 1053\u20131054 (2013).","journal-title":"Mol. psychiatry"},{"key":"1349_CR76","first-page":"548","volume":"24","author":"P Chakrabarty","year":"2010","unstructured":"Chakrabarty, P. et al. Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB. J.: . Publ. Federation Am. Societies Exp. Biol. 24, 548\u2013559 (2010).","journal-title":"J.: . Publ. Federation Am. Societies Exp. Biol."},{"key":"1349_CR77","doi-asserted-by":"publisher","first-page":"13629","DOI":"10.1523\/JNEUROSCI.1353-14.2014","volume":"34","author":"L Forny-Germano","year":"2014","unstructured":"Forny-Germano, L. et al. Alzheimer\u2019s disease-like pathology induced by amyloid-beta oligomers in nonhuman primates. J. Neurosci.: . J. Soc. Neurosci. 34, 13629\u201313643 (2014).","journal-title":"J. Neurosci.: . J. Soc. Neurosci."},{"key":"1349_CR78","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI57256","volume":"122","author":"TR Bomfim","year":"2012","unstructured":"Bomfim, T. R. et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease-associated Abeta oligomers. J. Clin. Investig. 122, 1339\u20131353 (2012).","journal-title":"J. Clin. Investig."},{"key":"1349_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2019.03.016","volume":"316","author":"ESNM Lyra","year":"2019","unstructured":"Lyra, E. S. N. M. et al. Understanding the link between insulin resistance and Alzheimer\u2019s disease: Insights from animal models. Exp. Neurol. 316, 1\u201311 (2019).","journal-title":"Exp. Neurol."},{"key":"1349_CR80","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/acel.12498","volume":"15","author":"YF Mao","year":"2016","unstructured":"Mao, Y. F. et al. Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe\/PS1dE9 mice. Aging cell 15, 893\u2013902 (2016).","journal-title":"Aging cell"},{"key":"1349_CR81","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot, K. et al. Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Investig. 122, 1316\u20131338 (2012).","journal-title":"J. Clin. Investig."},{"key":"1349_CR82","doi-asserted-by":"crossref","unstructured":"H. H. Ruiz et al. 2016 Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer\u2019s disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels Alzheimer\u2019s Dement.: J. Alzheimer\u2019s Assoc. 12 851\u2013861.","DOI":"10.1016\/j.jalz.2016.01.008"},{"key":"1349_CR83","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1084\/jem.20161731","volume":"214","author":"E Marciniak","year":"2017","unstructured":"Marciniak, E. et al. Tau deletion promotes brain insulin resistance. J. Exp. Med 214, 2257\u20132269 (2017).","journal-title":"J. Exp. Med"},{"key":"1349_CR84","doi-asserted-by":"publisher","first-page":"42394","DOI":"10.1074\/jbc.C200444200","volume":"277","author":"L Rui","year":"2002","unstructured":"Rui, L., Yuan, M., Frantz, D., Shoelson, S. & White, M. F. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277, 42394\u201342398 (2002).","journal-title":"J. Biol. Chem."},{"key":"1349_CR85","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2337\/db12-0443","volume":"62","author":"SB Jorgensen","year":"2013","unstructured":"Jorgensen, S. B. et al. Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity. Diabetes 62, 56\u201364 (2013).","journal-title":"Diabetes"},{"key":"1349_CR86","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.molmet.2014.06.001","volume":"3","author":"JA Pedroso","year":"2014","unstructured":"Pedroso, J. A. et al. Inactivation of SOCS3 in leptin receptor-expressing cells protects mice from diet-induced insulin resistance but does not prevent obesity. Mol. Metab. 3, 608\u2013618 (2014).","journal-title":"Mol. Metab."},{"key":"1349_CR87","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.nbd.2010.09.018","volume":"41","author":"S Hashioka","year":"2011","unstructured":"Hashioka, S., Klegeris, A., Qing, H. & McGeer, P. L. STAT3 inhibitors attenuate interferon-gamma-induced neurotoxicity and inflammatory molecule production by human astrocytes. Neurobiol. Dis. 41, 299\u2013307 (2011).","journal-title":"Neurobiol. Dis."},{"key":"1349_CR88","doi-asserted-by":"publisher","first-page":"e9665","DOI":"10.15252\/emmm.201809665","volume":"11","author":"N Reichenbach","year":"2019","unstructured":"Reichenbach, N. et al. Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer\u2019s disease model. EMBO Mol. Med. 11, e9665 (2019).","journal-title":"EMBO Mol. Med."},{"key":"1349_CR89","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.neuron.2011.11.024","volume":"73","author":"CS Nicolas","year":"2012","unstructured":"Nicolas, C. S. et al. The Jak\/STAT pathway is involved in synaptic plasticity. Neuron 73, 374\u2013390 (2012).","journal-title":"Neuron"},{"key":"1349_CR90","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.2174\/15665240113139990076","volume":"13","author":"E Chen","year":"2013","unstructured":"Chen, E. et al. A novel role of the STAT3 pathway in brain inflammation-induced human neural progenitor cell differentiation. Curr. Mol. Med 13, 1474\u20131484 (2013).","journal-title":"Curr. Mol. Med"},{"key":"1349_CR91","doi-asserted-by":"publisher","first-page":"17501","DOI":"10.1073\/pnas.0607207103","volume":"103","author":"MD Saxe","year":"2006","unstructured":"Saxe, M. D. et al. Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus. Proc. Natl Acad. Sci. USA 103, 17501\u201317506 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1349_CR92","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3233\/JAD-2010-1308","volume":"19","author":"SJ Greco","year":"2010","unstructured":"Greco, S. J. et al. Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 19, 1155\u20131167 (2010).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"1349_CR93","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","volume":"118","author":"RD Bell","year":"2009","unstructured":"Bell, R. D. & Zlokovic, B. V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer\u2019s disease. Acta Neuropathologica 118, 103\u2013113 (2009).","journal-title":"Acta Neuropathologica"},{"key":"1349_CR94","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-008-0366-2","volume":"115","author":"DR Thal","year":"2008","unstructured":"Thal, D. R., Griffin, W. S., de Vos, R. A. & Ghebremedhin, E. Cerebral amyloid angiopathy and its relationship to Alzheimer\u2019s disease. Acta Neuropathologica 115, 599\u2013609 (2008).","journal-title":"Acta Neuropathologica"},{"key":"1349_CR95","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/jnnp.74.1.70","volume":"74","author":"JM Starr","year":"2003","unstructured":"Starr, J. M. et al. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J. Neurol. Neurosurg. Psychiatry 74, 70\u201376 (2003).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1349_CR96","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1464-5491.1995.tb00544.x","volume":"12","author":"MJ Stevens","year":"1995","unstructured":"Stevens, M. J., Feldman, E. L. & Greene, D. A. The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diabet. Med.: J. Br. Diabet. Assoc. 12, 566\u2013579 (1995).","journal-title":"Diabet. Med.: J. Br. Diabet. Assoc."},{"key":"1349_CR97","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.3390\/ijms21062194","volume":"21","author":"EY Ting","year":"2020","unstructured":"Ting, E. Y., Yang, A. C. & Tsai, S. J. Role of Interleukin-6 in depressive disorder. Int. J. Mol. Sci. 21, 2194 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1349_CR98","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","volume":"63","author":"RL Ownby","year":"2006","unstructured":"Ownby, R. L., Crocco, E., Acevedo, A., John, V. & Loewenstein, D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch. Gen. Psychiatry 63, 530\u2013538 (2006).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1349_CR99","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1212\/WNL.0000000000001617","volume":"84","author":"J Butchart","year":"2015","unstructured":"Butchart, J. et al. Etanercept in Alzheimer disease: a randomized, placebo-controlled, double-blind, phase 2 trial. Neurology 84, 2161\u20132168 (2015).","journal-title":"Neurology"},{"key":"1349_CR100","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s40266-015-0239-z","volume":"32","author":"M Miguel-Alvarez","year":"2015","unstructured":"Miguel-Alvarez, M. et al. Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer\u2019s disease: a systematic review and meta-analysis of treatment effect. Drugs Aging 32, 139\u2013147 (2015).","journal-title":"Drugs Aging"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01349-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01349-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01349-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:01:49Z","timestamp":1669899709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01349-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["1349"],"URL":"https:\/\/doi.org\/10.1038\/s41398-021-01349-z","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]},"assertion":[{"value":"30 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"251"}}